In June 2020, BSV formed a strategic alliance with LaVoieHealthScience in order to enhance BSV's capabilities to communicate value. <read more here>                     In May 2020, BSV entered into a strategic alliance with FCF Fox Corporate Finance to support funding activities. <read more here>                    
 
                           COVID-19 Portal               Home      About      Team      Clients      Publications      Downloads      News      Career      Contact

Testimonials
  Bioscience Valuation's comprehensive assessments of in-licensing candidates provide us with a thorough understanding of the opportunity, both from a scientific and business perspective.

Dr. Philipp R. Hoffmann, Senior Director Business Development & Licensing Europe, Daiichi Sankyo

 

Core Services
  Financial Valuation
  Commercial Assessment &
Pharmacoeconomics

  R&D Risk Analysis &
Productivity Increase

  Portfolio Management
  Investment Decisions
  Partnering / Licensing
  Corporate Finance / M&A

Special Expertise
  Economic Modeling
of Healthcare Systems

  Assessing the Economics
of Personalized Medicine

Comprehensive Support
  Corporate Partnership Program

Products
  Market Model
  R&D Risk Model
  Valuation Model


Contact - Bioscience Valuation

Bioscience Valuation BSV GmbH
Am Zigeunerbergl 3
82491 Grainau
Germany
Phone: +49 8821 966979-0
Fax: +49 8821 966979-29
E-Mail: contact@bioscience-valuation.com


US Representative Office
Dr. Doug Morgan
81 Spring Pond Drive
Ossining, New York 10562
USA
Phone: +1 914-215-0265
E-Mail: d.morgan@bioscience-valuation.com



















This website uses cookies to ensure you get the best experience on our website.
Privacy Policy